Semaglutide and Constipation: Causes, Management, and When to Call Your Doctor

Nausea gets most of the attention when people talk about semaglutide side effects. Constipation deserves its own conversation. It affects roughly one in four people who start semaglutide treatment, and unlike nausea, it does not always resolve quickly on its own.

The good news: constipation on semaglutide is manageable for most people with targeted dietary changes, hydration, and some patience. Understanding why it happens is the first step toward addressing it effectively. This guide covers the mechanism, what clinical trial data shows about how common it is, practical strategies that help, and the specific signs that warrant a call to your provider.

*Compounded semaglutide is not FDA-approved. This article is for educational and informational purposes only and does not constitute medical advice. Individual results vary. Always consult your licensed healthcare provider before starting or adjusting any medication.*

---

Why Semaglutide Causes Constipation

Semaglutide works by mimicking GLP-1, a hormone your gut naturally releases in response to food. GLP-1 receptors are distributed throughout the gastrointestinal tract, and when activated, they slow the rate at which food moves through the digestive system. This is the intended therapeutic mechanism. Slower gastric emptying extends the feeling of fullness and reduces appetite.

That same slowing effect, however, applies to the entire GI tract, not just the stomach. As food moves more slowly through the small and large intestine, the colon has more time to absorb water from its contents. The result is stool that is drier, harder, and more difficult to pass.

GLP-1 receptors also appear to directly reduce colonic motility, the muscular contractions that propel stool through the large intestine. Research in the journal *Neurogastroenterology and Motility* has demonstrated that GLP-1 activity in the enteric nervous system, the network of neurons lining the gut, contributes to reduced bowel movement frequency beyond the gastric emptying effect alone (Tack J et al., 2012; PMID: 22309540).

Put simply: semaglutide slows digestion at multiple points simultaneously. For some people that means constipation.

---

What the Clinical Trials Show

The STEP 1 trial, one of the largest and most rigorous semaglutide studies conducted, enrolled 1,961 adults with obesity and followed them for 68 weeks on semaglutide 2.4 mg weekly. (STEP 1 studied FDA-approved branded semaglutide, Wegovy; compounded semaglutide is a separate, non-FDA-approved formulation, and incidence rates for compounded versions have not been established in controlled trials.) Constipation was reported by 24.2% of participants in the semaglutide group, compared to 11.1% in the placebo group. This puts constipation among the most common GLP-1 side effects after nausea and vomiting (Wilding JPH et al., 2021; PMID: 33567185).

The STEP 4 trial, which enrolled participants who had already completed an initial 20-week treatment period, found similar rates of constipation during the continuation phase. Importantly, constipation in STEP 4 was reported throughout the maintenance period, suggesting that for some people it persists beyond the initial adjustment phase rather than resolving as the body adapts (Rubino D et al., 2021; PMID: 33755728).

STEP 5, the two-year extension trial, provided a longer-term view. While nausea and vomiting largely resolved by the maintenance phase, gastrointestinal adverse events including constipation continued to be reported by a subset of participants at the two-year mark, though at lower rates than during titration (Garvey WT et al., 2022; PMID: 35653009).

The practical takeaway from this data: constipation on semaglutide is very common, particularly during dose escalation, and is less likely to resolve spontaneously than nausea. Active management is usually necessary.

---

The Constipation-Reduced Appetite Connection

There is one dynamic unique to semaglutide constipation that is worth understanding. When appetite is significantly reduced, total food intake drops substantially. Less food volume means less material moving through the digestive tract. Lower food bulk, combined with semaglutide's slowing of gut motility, creates a compounding effect.

Reduced fiber intake is a common downstream consequence. If you were previously getting adequate fiber from a larger volume of food and now find yourself eating much less, your fiber intake may have dropped significantly without you noticing it. Fiber is the primary driver of stool bulk and water retention in the colon. When intake falls, constipation often follows.

This connection also explains why constipation on semaglutide sometimes worsens as the medication becomes more effective at reducing appetite. The more it works, the less you eat, and without intentional attention to fiber and fluid intake, the harder constipation becomes to manage.

---

*Dietary fiber is the most evidence-backed intervention for semaglutide-related constipation. Aim for 25 to 38 grams daily from whole food sources.*

---

6 Strategies That Help Most People

These approaches work with the physiology of how semaglutide affects gut motility. None of them are complicated, but they require consistency.

1. Increase Fiber Intake, Gradually

Dietary fiber is the foundation of constipation management. Soluble fiber, found in oats, beans, lentils, apples, and psyllium husk, absorbs water and forms a gel that softens stool. Insoluble fiber, found in whole grains, wheat bran, and most vegetables, adds bulk and helps push material through the colon.

The target for adults is 25 to 38 grams of fiber daily, depending on sex and body weight, according to guidelines from the American College of Gastroenterology (Ford AC et al., 2014; PMID: 24813350). Most people eating on a semaglutide-reduced appetite get far less than that.

Important: increase fiber gradually rather than all at once. Adding too much fiber too quickly can cause bloating, gas, and cramping. A better approach is to increase fiber by 5 grams per week until you reach an adequate intake. Psyllium husk (plain, unflavored versions like Metamucil or generic psyllium powder) is one of the most effective and practical ways to add soluble fiber when food intake is reduced.

2. Drink More Water Than You Think You Need

Fiber without adequate hydration makes constipation worse, not better. Fiber requires water to do its job. If your fluid intake is low, added fiber simply becomes harder, bulkier stool that is even more difficult to pass.

A general target of 8 to 10 cups (64 to 80 oz) of water daily is reasonable for most adults, though individual needs vary based on body size, activity level, and climate. On semaglutide, the reduced appetite that decreases food intake often decreases the drive to drink as well. Deliberate, consistent hydration throughout the day matters more than ever.

Plain water is best. Caffeinated beverages, including coffee and many teas, have a mild diuretic effect. While moderate coffee consumption is generally fine, relying on caffeinated drinks for fluid intake is less effective than water.

3. Move Your Body Daily

Physical activity is one of the most underappreciated tools for managing constipation. Exercise stimulates peristalsis, the rhythmic muscle contractions that propel stool through the colon. Even modest daily movement, like a 20 to 30 minute walk, has been shown to reduce constipation frequency and severity in clinical populations (de Oliveira EP & Burini RC, 2009; PMID: 19568184).

This is especially relevant for people who are sedentary. If a reduced-calorie diet and medication side effects have made you more tired than usual, prioritizing even light daily activity can meaningfully support digestive function.

4. Build Consistent Bathroom Habits

Gastrocolic reflex refers to the increase in colonic activity that follows eating. This is the body's natural signal to make room for incoming food. The reflex is strongest after the first meal of the day, which is why many people find that the best time for a bowel movement is in the morning after breakfast.

On semaglutide, eating less means a weaker gastrocolic reflex signal. Counter this by making time after your first meal of the day a consistent routine for attempting a bowel movement, even if the urge is not strong. Sitting on the toilet for 5 to 10 minutes after a meal allows the reflex to work without pressure or urgency. Over time, this trains a more regular pattern.

Squatting-position toilet stools, which elevate the feet slightly and align the colon for easier passage, have some evidence supporting their use for reducing straining and improving evacuation completeness (Sikirov D, 2003; PMID: 12839282).

5. Consider Osmotic Laxatives for Short-Term Relief

When dietary changes are not providing adequate relief, osmotic laxatives are a safe and well-evidence-backed option for short-term use. These work by drawing water into the colon, softening stool without stimulating muscular contractions.

Polyethylene glycol (PEG), sold as Miralax, is one of the most studied and gentle options. It is non-habit-forming, works within one to three days, and is widely recommended in gastroenterology guidelines for managing functional constipation (Ford AC et al., 2014; PMID: 24813350). Magnesium citrate and magnesium oxide are alternatives in the same osmotic category.

Stimulant laxatives (senna, bisacodyl) work by directly stimulating colon contractions. They provide faster relief but carry a higher risk of cramping and are not recommended for regular or long-term use. If you need occasional relief and dietary changes are not enough, osmotic laxatives are the better starting point.

Always discuss any new supplements or laxative use with your provider before starting, particularly if you have kidney disease, heart conditions, or other medical considerations.

6. Look at Your Overall Eating Pattern

Because reduced appetite is driving lower food and fiber intake, the specific composition of what you do eat becomes more important. Prioritizing fiber-rich foods within a smaller eating volume is the goal.

Practical choices that maximize fiber per calorie: legumes (lentils, chickpeas, black beans), raspberries and blackberries, cooked artichokes, split peas, avocado, and oatmeal. These deliver meaningful fiber in small portions. For more detailed guidance on eating patterns during semaglutide treatment, see the guide on [what to eat on semaglutide](/articles/what-to-eat-on-semaglutide).

---

Foods That Often Make It Worse

Certain foods, many of which are easy to lean on when appetite is low, tend to worsen constipation. Low-fiber, high-fat processed foods are the main category.

Reduce or avoid:

• White bread, white rice, and refined grain products (low fiber, slow gut transit)
• Processed snacks, crackers, and chips (low fiber, often high in salt that increases dehydration)
• Red meat in large quantities (low fiber, slower to digest)
• Dairy products in excess (can contribute to constipation in some individuals)
• Alcohol (dehydrating, can worsen constipation; see the guide on [semaglutide and alcohol](/articles/semaglutide-and-alcohol))

This does not mean eliminating these foods entirely. It means being aware that when overall food intake is reduced, the composition of what you eat has more impact on digestive function than when you are eating larger volumes.

---

When to Call Your Doctor

Most constipation on semaglutide responds to the strategies above within one to two weeks of consistent effort. There are situations where constipation warrants a prompt call to your provider rather than continued home management.

Contact your provider if:

• You have not had a bowel movement in more than four to five days, particularly if accompanied by abdominal discomfort, bloating, or nausea. Prolonged constipation can lead to fecal impaction, a condition where hardened stool cannot be passed without medical intervention.

• You experience severe or worsening abdominal pain. Pain that is sharp, cramping, or significantly different from typical constipation discomfort may indicate a more serious issue, including possible intestinal obstruction or ileus (cessation of normal bowel movements). While these are rare, GLP-1 medications have been associated with ileus in post-marketing reports.

• You notice blood in your stool or significant rectal bleeding. Small amounts of bright red blood after straining can result from hemorrhoids or minor anal fissures, both of which are more likely when constipation causes straining. However, blood in stool always warrants evaluation to rule out other causes.

• Constipation is accompanied by vomiting, inability to pass gas, or significant abdominal distension. This combination of symptoms may indicate bowel obstruction and requires prompt medical attention.

• Constipation persists despite four to six weeks of consistent dietary changes, adequate hydration, and over-the-counter osmotic laxative use. Your provider may need to adjust your semaglutide dose, consider a prescription-strength intervention, or investigate whether another cause is contributing.

• You are taking other medications that can cause or worsen constipation, including opioids, iron supplements, calcium channel blockers, or certain antidepressants. The combination of these with semaglutide's gut-slowing effects can be additive and may require coordinated management.

Do not stop semaglutide without talking to your provider first. Constipation is manageable and rarely a reason to discontinue treatment on its own. Your provider can help you find the right combination of dose adjustment and supportive interventions to continue safely.

---

The Bottom Line

Constipation is one of the more common and persistent GLP-1 side effects, affecting roughly one in four people on semaglutide. Unlike nausea, it does not reliably resolve on its own as the body adapts. Active management through increased fiber intake, consistent hydration, daily movement, and thoughtful eating habits gives most people meaningful relief.

The strategies outlined here are grounded in well-established gastroenterology guidelines and the physiological logic of how semaglutide affects gut function. They take a few weeks of consistent effort to show full results, so patience matters as much as the actions themselves.

If constipation is not responding to home management, if it is severe or accompanied by significant pain, or if you notice red flag symptoms like blood in stool or inability to pass gas, contact your provider. These are situations where guidance and possibly intervention are warranted, not symptoms to wait out on your own.

*This article is for informational and educational purposes only. It is not medical advice. Compounded semaglutide is not FDA-approved. Consult a licensed healthcare provider before starting or adjusting any medication.*

---

References

1. Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." *New England Journal of Medicine.* 2021;384(11):989-1002. PMID: 33567185.

1. Rubino D, et al. "Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial." *JAMA.* 2021;325(14):1414-1425. PMID: 33755728.

1. Garvey WT, et al. "Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial." *Nature Medicine.* 2022;28(10):2083-2091. PMID: 35653009.

1. Tack J, et al. "Gastrointestinal mechanisms underpinning the side effects of glucagon-like peptide-1 receptor agonists." *Neurogastroenterology and Motility.* 2012;24(12):1082-1091. PMID: 22309540.

1. Ford AC, et al. "American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation." *American Journal of Gastroenterology.* 2014;109 Suppl 1:S2-26. PMID: 24813350.

1. de Oliveira EP, Burini RC. "The impact of physical exercise on the gastrointestinal tract." *Current Opinion in Clinical Nutrition and Metabolic Care.* 2009;12(5):533-538. PMID: 19568184.

1. Sikirov D. "Comparison of straining during defecation in three positions: results and implications for human health." *Digestive Diseases and Sciences.* 2003;48(7):1201-1205. PMID: 12839282.